-
1 . Academic Journal
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
- 저자
- by Beesley, Richard; Churchill, Vicky; Insch, Elspeth; Loughton, Holly; MacDonald, Eilean, et al.
- 소스
- In The Lancet Rheumatology June 2024 6(6):e339-e351